APDUCE
Live / Registered — Registered (as of 26 Sept 2023)
What this means for you
Registered since 26 Sept 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97412748
- Registration number
- 7172959
- Mark type
- Stylized text
- Filed
- 16 May 2022
- Published for opposition
- 11 Jul 2023
- Registered
- 26 Sept 2023
- Attorney of record
- Kathryn E. Smith
Goods and services
- Class 005 — Pharmaceuticals: Chemical preparations for medical purposes, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; drugs sold in bulk, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; biochemical medicines for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; medicines for human purposes for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; chemico-pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; drugs for medical purposes in the nature of prescription apoptosis targeted compounds, next-generation kinase inhibitors and senolytic drugs; biological preparations for medical purposes, namely, biological preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; chemical preparations for pharmaceutical purposes, namely, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; radioactive substances for medical purposes; gases for medical purposes, namely, nitric oxide for medical purposes; chemical conductors for electrocardiograph electrodes; semen for artificial insemination; disinfectants; solutions for contact lenses; media for bacteriological cultures; medicated sweets; dietetic preparations adapted for medical use; depuratives for the body; diagnostic preparations for veterinary purposes; pesticides; sanitary napkins; cotton for medical purposes; dental abrasives; diapers for pets
Owner
- ASCENTAGE PHARMA (SUZHOU) CO., LTD., JIANGSU, CN
- ASCENTAGE PHARMA (SUZHOU) CO., LTD., JIANGSU, CN
- ASCENTAGE PHARMA (SUZHOU) CO., LTD., JIANGSU, CN
Prosecution history
- 26 Sept 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 26 Sept 2023 — REGISTERED-PRINCIPAL REGISTER
- 11 Jul 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Jul 2023 — PUBLISHED FOR OPPOSITION
- 21 Jun 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 Jun 2023 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 27 May 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 May 2023 — EXAMINER'S AMENDMENT ENTERED
- 27 May 2023 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 27 May 2023 — EXAMINERS AMENDMENT E-MAILED
- 27 May 2023 — EXAMINERS AMENDMENT -WRITTEN
- 24 Apr 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Apr 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Apr 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 12 Mar 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED